Published in Healthcare Mergers, Acquisitions and Ventures Week, September 18th, 2004
During the corresponding period of the previous year, the company reported net income of $810,000, equal to 16 cents per diluted share, on sales of $14,023,000.
During the six-month period of the current fiscal year, earnings were $2,201,000, equal to 38 cents per diluted share, on sales of $28,232,000. For the corresponding period last year the company reported a net profit of $1,316,000, equal to 27 cents per diluted share, on sales of $27,237,000.
Commenting on the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.